Tandem Diabetes Care, Inc. Income Tax Expense
Tandem Diabetes Care, Inc. (TNDM) reported Income Tax Expense of $510.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06
- Tandem Diabetes Care, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $510.00K.
- Tandem Diabetes Care, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $516.00K, a 93.91% decline year-over-year.
- Tandem Diabetes Care, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $5.27M.
- Tandem Diabetes Care, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was -$3.98M, a 724.49% decline year-over-year.
- Tandem Diabetes Care, Inc. income tax expense (benefit) for fiscal 2025 was $4.44M, a 6.81% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. income tax expense (benefit) for fiscal 2024 was $4.16M, a 76.28% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. income tax expense (benefit) for fiscal 2023 was $2.36M, a 35.30% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. income tax expense (benefit) for fiscal 2022 was $1.74M, a 420.00% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $510.00K 10-Q · filed 2026-08-06 | $1.03M 10-Q · filed 2026-08-06 | $6.30M derived: sum of 3 quarters · filed 2026-08-06 | $2.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $516.00K 10-Q · filed 2026-05-07 | $5.79M derived: sum of 2 quarters · filed 2026-05-07 | $1.81M derived: sum of 3 quarters · filed 2026-05-07 | -$3.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $5.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.29M derived: sum of 2 quarters · filed 2026-02-19 | -$4.03M derived: sum of 3 quarters · filed 2026-08-06 | $4.44M 10-K · filed 2026-02-19 |
| 2025-09-30 | -$3.98M 10-Q · filed 2025-11-06 | -$9.30M derived: sum of 2 quarters · filed 2026-08-06 | -$833.00K 10-Q · filed 2025-11-06 | -$1.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$5.32M 10-Q · filed 2026-08-06 | $3.15M 10-Q · filed 2026-08-06 | $2.41M derived: sum of 3 quarters · filed 2026-08-06 | $3.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $8.47M 10-Q · filed 2026-05-07 | $7.73M derived: sum of 2 quarters · filed 2026-05-07 | $8.37M derived: sum of 3 quarters · filed 2026-05-07 | $9.44M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$739.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$102.00K derived: sum of 2 quarters · filed 2026-02-19 | $969.00K derived: sum of 3 quarters · filed 2026-02-19 | $4.16M 10-K · filed 2026-02-19 |
| 2024-09-30 | $637.00K 10-Q · filed 2025-11-06 | $1.71M derived: sum of 2 quarters · filed 2025-11-06 | $4.89M 10-Q · filed 2025-11-06 | $3.59M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.07M 10-Q · filed 2025-08-06 | $4.26M 10-Q · filed 2025-08-06 | $2.95M derived: sum of 3 quarters · filed 2026-02-19 | $5.18M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $3.19M 10-Q · filed 2025-04-30 | $1.88M derived: sum of 2 quarters · filed 2026-02-19 | $4.11M derived: sum of 3 quarters · filed 2026-02-19 | $5.26M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $924.00K derived: sum of 2 quarters · filed 2026-02-19 | $2.07M derived: sum of 3 quarters · filed 2026-02-19 | $2.36M 10-K · filed 2026-02-19 |
| 2023-09-30 | $2.23M 10-Q · filed 2024-11-06 | $3.38M derived: sum of 2 quarters · filed 2024-11-06 | $3.67M 10-Q · filed 2024-11-06 | $3.40M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $1.15M 10-Q · filed 2024-08-01 | $1.43M 10-Q · filed 2024-08-01 | $1.17M derived: sum of 3 quarters · filed 2025-02-26 | $2.79M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $287.00K 10-Q · filed 2024-05-02 | $26.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.65M derived: sum of 3 quarters · filed 2025-02-26 | $3.75M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.36M derived: sum of 2 quarters · filed 2025-02-26 | $3.47M derived: sum of 3 quarters · filed 2025-02-26 | $1.74M 10-K · filed 2025-02-26 |
| 2022-09-30 | $1.62M 10-Q · filed 2023-11-01 | $3.73M derived: sum of 2 quarters · filed 2023-11-01 | $2.00M 10-Q · filed 2023-11-01 | $2.34M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $2.11M 10-Q · filed 2023-08-03 | $382.00K 10-Q · filed 2023-08-03 | $719.00K derived: sum of 3 quarters · filed 2024-02-21 | $773.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$1.72M 10-Q · filed 2023-05-03 | -$1.39M derived: sum of 2 quarters · filed 2024-02-21 | -$1.33M derived: sum of 3 quarters · filed 2024-02-21 | -$1.27M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $391.00K derived: sum of 2 quarters · filed 2024-02-21 | $452.00K derived: sum of 3 quarters · filed 2024-02-21 | $335.00K 10-K · filed 2024-02-21 |
| 2021-09-30 | $54.00K 10-Q · filed 2022-11-02 | $115.00K derived: sum of 2 quarters · filed 2022-11-02 | -$2.00K 10-Q · filed 2022-11-02 | $36.00K derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $61.00K 10-Q · filed 2022-08-03 | -$56.00K 10-Q · filed 2022-08-03 | -$18.00K derived: sum of 3 quarters · filed 2023-02-22 | $21.00K derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | -$117.00K 10-Q · filed 2022-05-04 | -$79.00K derived: sum of 2 quarters · filed 2023-02-22 | -$40.00K derived: sum of 3 quarters · filed 2023-02-22 | -$2.12M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $77.00K derived: sum of 2 quarters · filed 2023-02-22 | -$2.00M derived: sum of 3 quarters · filed 2023-02-22 | -$1.90M 10-K · filed 2023-02-22 |
| 2020-09-30 | $39.00K 10-Q · filed 2021-11-03 | -$2.04M derived: sum of 2 quarters · filed 2021-11-03 | -$1.94M 10-Q · filed 2021-11-03 | -$1.86M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | -$2.08M 10-Q · filed 2021-08-04 | -$1.98M 10-Q · filed 2021-08-04 | -$1.90M derived: sum of 3 quarters · filed 2022-02-22 | -$1.83M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $98.00K 10-Q · filed 2021-05-05 | $175.00K derived: sum of 2 quarters · filed 2022-02-22 | $247.00K derived: sum of 3 quarters · filed 2022-02-22 | $247.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $149.00K derived: sum of 2 quarters · filed 2022-02-22 | $149.00K derived: sum of 3 quarters · filed 2022-02-22 | $149.00K 10-K · filed 2022-02-22 |
| 2019-09-30 | $72.00K 10-Q · filed 2020-11-05 | $72.00K derived: sum of 2 quarters · filed 2020-11-05 | $72.00K 10-Q · filed 2020-11-05 | $123.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $0.00 10-Q · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | $51.00K derived: sum of 3 quarters · filed 2021-02-24 | $51.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $0.00 10-Q · filed 2020-04-30 | $51.00K derived: sum of 2 quarters · filed 2021-02-24 | $51.00K derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $51.00K derived: sum of 2 quarters · filed 2021-02-24 | $51.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | ||
| 2017-12-31 | $8.00K 10-K · filed 2020-02-24 | |||
| 2016-12-31 | -$15.00K 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $10.00K 10-K · filed 2018-03-01 | |||
| 2014-12-31 | $71.00K 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |